To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CLSPNTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
154 supporting clones for gene CLSPN back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DW429941 Liver .a 1 to 385 10 to 394   tiling clone,   385/394
(97 %)
6 diff
(98.5 %id)
DW451413 Liver .a 1 to 369 10 to 378       369/378
(97 %)
5 diff
(98.7 %id)
BP283759 bone marrow .a 17 to 604 1 to 588       588/588
(100 %)
6 diff
(99.0 %id)
CX163242 human embryonic stem cells differentiated toan early endodermal cell type .a 21 to 858 1 to 838       838/838
(100 %)
0 diff
(100 %id)
AL699150 human skeletal muscle .a 22 to 608 1 to 587       587/587
(100 %)
2 diff
(99.7 %id)
DW426478 Liver .a 22 to 289 15 to 282       268/282
(95 %)
8 diff
(97.2 %id)
BU181027 embryonal carcinoma, cell line, testis .a 24 to 904 1 to 882       882/883
(99 %)
13 diff
(98.6 %id)
DA004627   .a 25 to 600 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
AK308193   .a 25 to 1500 1 to 1477       1477/1477
(100 %)
6 diff
(99.6 %id)
DA465025   .a 25 to 518 78 to 571   capped   494/570
(86 %)
6 diff
(99.0 %id)
BP364067 lung .a 25 to 607 1 to 583       583/583
(100 %)
0 diff
(100 %id)
BP281199 bone marrow .a 26 to 609 1 to 584       584/586
(99 %)
3 diff
(99.5 %id)
DA882168   .a 26 to 591 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
BP364700 lung .a 28 to 605 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BC062215 Pooled, 40 cell lines .a 30 to 436 1 to 407   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 407/418
(97 %)
9 diff
(97.9 %id)
BU960015 mixed (pool of 40 RNAs) .a 31 to 428 1 to 398   available from MGC,   398/982
(40 %)
11 diff
(98.9 %id)
BC018670 Bone marrow, acute myelogenous leukemia .a 36 to 2076 4 to 2044   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 2041/2072
(98 %)
1 diff
(100.0 %id)
BF242396 bone marrow, from acute myelogenous leukemia .a 36 to 712 1 to 678   available from MGC,   678/919
(73 %)
33 diff
(96.5 %id)
DA612873   .a 36 to 615 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
BP221815   .a 39 to 620 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DN919772   .a 39 to 550 512 to 1       512/513
(99 %)
3 diff
(99.5 %id)
DN919773   .a 39 to 550 11 to 522       512/522
(98 %)
9 diff
(98.3 %id)
DN913531   .a 44 to 99 1 to 56       56/56
(100 %)
1 diff
(98.3 %id)
DN913254   .a 45 to 508 11 to 474       464/474
(97 %)
8 diff
(98.4 %id)
DN916760   .a 45 to 627 16 to 597       582/597
(97 %)
18 diff
(97.0 %id)
DN919169   .a 45 to 684 32 to 666       635/703
(90 %)
12 diff
(98.3 %id)
BC038991 Skin, melanotic melanoma. .a 50 to 2211 24 to 2185   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 2162/2176
(99 %)
10 diff
(99.6 %id)
BQ227287 melanotic melanoma, skin .a 50 to 720 24 to 695   available from MGC,   672/898
(74 %)
16 diff
(98.3 %id)
DN916761   .a 51 to 679 634 to 6       629/636
(98 %)
0 diff
(100 %id)
CN309666 embryonic stem cells, DMSO-treated H9 cellline .a 52 to 404 1 to 353       353/353
(100 %)
0 diff
(100 %id)
NM_022111.3   .a 53 to 8536 1 to 8484 exact RefSeq,   8484/8484
(100 %)
0 diff
(100 %id)
BC113116 PCR rescued clones .a 71 to 4252 12 to 4192 exact     4181/4199
(99 %)
16 diff
(99.7 %id)
BC115026 PCR rescued clones .a 71 to 4252 12 to 4192 P324S H344R T387A E633Q E901G ...     4181/4193
(99 %)
21 diff
(99.5 %id)
BC115023 PCR rescued clones .a 71 to 4252 1 to 4179 A332V K565M C944F S945R G946K ...     4179/4187
(99 %)
13 diff
(99.7 %id)
BC115027 PCR rescued clones .a 71 to 4252 11 to 4190 A24V T79L T80P Y81M D82T ...     4180/4196
(99 %)
22 diff
(99.5 %id)
BC137279 Pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones .a 74 to 4353 1 to 4280 exact tiling clone,   4280/4280
(100 %)
0 diff
(100 %id)
BC140789 Pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones .a 74 to 4353 1 to 4280 exact     4280/4280
(100 %)
0 diff
(100 %id)
DN919170   .a 83 to 679 602 to 6       597/602
(99 %)
0 diff
(100 %id)
BI019346 marrow .a 137 to 428 1 to 293       293/417
(70 %)
3 diff
(99.3 %id)
DB294043   .a 329 to 1114 2 to 791   capped   790/790
(100 %)
10 diff
(98.8 %id)
R16189 whole brain .a 956 to 1305 1 to 358       358/374
(95 %)
10 diff
(97.4 %id)
TI_1968231589   .a 1152 to 2312 1 to 1145       1145/1267
(90 %)
20 diff
(98.5 %id)
BU662956 blood .a 1194 to 1822 1 to 629       629/656
(95 %)
5 diff
(99.3 %id)
BG469801 adenocarcinoma cell line, colon .a 1204 to 2024 1 to 823       823/823
(100 %)
8 diff
(99.1 %id)
BM799186 Ascites, stomach .a 1300 to 1828 1 to 529       529/529
(100 %)
1 diff
(99.9 %id)
BM720876 eye, fetal eye .a 1582 to 2215 647 to 16   AAA Submitted on the opposite strand 632/647
(97 %)
3 diff
(99.6 %id)
AI569660 anaplastic oligodendroglioma, brain .a 1596 to 2089 494 to 1       494/494
(100 %)
0 diff
(100 %id)
DB384004   .a 1670 to 2196 532 to 3       530/541
(97 %)
14 diff
(97.5 %id)
TI_2194695954   .a 1702 to 2880 7 to 1181       1182/1307
(90 %)
76 diff
(94.2 %id)
TI_1959500063   .a 1713 to 2748 12 to 1043       1032/1221
(84 %)
13 diff
(99.0 %id)
TI_2194697429   .a 1714 to 2710 998 to 12       987/1295
(76 %)
66 diff
(95.0 %id)
BG166364 hypernephroma, cell line, Kidney .a 1714 to 2602 1 to 746       696/746
(93 %)
40 diff
(94.7 %id)
BM720808 eye, fetal eye .a 1749 to 2215 480 to 16   AAA Submitted on the opposite strand 465/481
(96 %)
10 diff
(98.0 %id)
R15753 whole brain .a 1753 to 2138 440 to 48       393/464
(84 %)
18 diff
(96.2 %id)
DN913524   .a 1757 to 2069 318 to 6       313/318
(98 %)
2 diff
(99.4 %id)
AW501258 lymph .a 1846 to 2076 8 to 238       231/238
(97 %)
7 diff
(97.1 %id)
AW500975 lymph .a 1846 to 2145 8 to 307       300/308
(97 %)
9 diff
(97.1 %id)
AW503075 lymph .a 1846 to 2034 8 to 196       189/196
(96 %)
7 diff
(96.5 %id)
AI206639 pooled germ cell tumors .a 1861 to 2198 339 to 1       339/339
(100 %)
9 diff
(97.4 %id)
AI635556 pooled germ cell tumors .a 1861 to 2198 338 to 1       338/338
(100 %)
0 diff
(100 %id)
BF968339 adrenal cortex carcinoma, cell line, adrenal gland .a 1883 to 2666 1 to 782       782/943
(82 %)
11 diff
(98.9 %id)
BX106982 whole brain .a 1885 to 2211 329 to 2       328/329
(99 %)
5 diff
(98.5 %id)
DB351844 uterus .a 6787 to 7310 524 to 1   tiling clone,   524/524
(100 %)
1 diff
(99.9 %id)
BG165037 hypernephroma, cell line, Kidney .a 7793 to 8549 1 to 751   tiling clone,   751/971
(77 %)
25 diff
(97.5 %id)
AI304876 carcinoid, lung .a 8109 to 8535 440 to 14   tiling clone, AAA   427/427
(100 %)
0 diff
(100 %id)
AW444677   .a 8114 to 8534 438 to 18   AAA   421/423
(99 %)
14 diff
(96.7 %id)
CN430732 embryonic stem cells, DMSO-treated H9 cellline .a 8157 to 8645 17 to 505   tiling clone,   489/505
(96 %)
6 diff
(98.9 %id)
AW449233   .a 8371 to 8535 182 to 18   AAA   165/165
(100 %)
0 diff
(100 %id)
AF297866   .b 1 to 4668 1 to 4654 F628S E664G F738S tiling clone, AAA   4727/4727
(100 %)
34 diff
(99.3 %id)
BC115024 PCR rescued clones .c 1 to 4023 10 to 4030 K287N A547T G683S E963G Y1064T ... tiling clone,   4021/4038
(99 %)
20 diff
(99.6 %id)
NM_001190481.1   .d 1 to 8292 1 to 8292 exact RefSeq,   8292/8292
(100 %)
0 diff
(100 %id)
BC115025 PCR rescued clones .d 19 to 4008 12 to 4000 S34G G446E S867G K869E tiling clone,   3989/4007
(99 %)
21 diff
(99.5 %id)
TI_1959499089   .d 21 to 1187 86 to 1248       1161/1286
(90 %)
45 diff
(96.6 %id)
TI_1968230469   .d 21 to 1055 84 to 1115   tiling clone,   1032/1263
(81 %)
10 diff
(99.3 %id)
FN142051 breast carcinoma .d 87 to 184 1 to 98       98/98
(100 %)
2 diff
(98.0 %id)
DN913530   .d 171 to 621 451 to 1       451/451
(100 %)
3 diff
(99.4 %id)
FN156213 breast carcinoma .d 277 to 392 1 to 118       118/118
(100 %)
2 diff
(98.4 %id)
DW418595 Liver .d 308 to 658 378 to 33   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 346/421
(82 %)
0 diff
(100 %id)
AA857451 pharynx, squamous cell carcinoma .d 332 to 811 480 to 1       480/480
(100 %)
0 diff
(100 %id)
EC513021 Prostate .d 370 to 473 1 to 103       103/103
(100 %)
3 diff
(97.1 %id)
BM461846 leiomyosarcoma, uterus .d 384 to 1250 1 to 875       875/930
(94 %)
18 diff
(98.1 %id)
BE882484 leiomyosarcoma, uterus .d 402 to 1086 1 to 685       685/942
(72 %)
8 diff
(99.2 %id)
AA857804 pharynx, squamous cell carcinoma .d 471 to 811 341 to 1       341/341
(100 %)
0 diff
(100 %id)
DN913253   .d 521 to 627 112 to 6       107/112
(95 %)
0 diff
(100 %id)
TI_1968231599   .d 536 to 1639 1 to 1089   tiling clone,   1089/1229
(88 %)
21 diff
(98.3 %id)
TI_1959500065   .d 543 to 1639 7 to 1093       1087/1261
(86 %)
17 diff
(98.7 %id)
BM676972 eye, fetal eye .d 631 to 1306 18 to 694     Submitted on the opposite strand 675/677
(99 %)
2 diff
(99.8 %id)
BM676911 eye, fetal eye .d 631 to 1086 18 to 474     Submitted on the opposite strand 455/467
(97 %)
9 diff
(98.1 %id)
BM828080 Ascites, stomach .d 654 to 1166 1 to 513       513/513
(100 %)
2 diff
(99.7 %id)
CN309667 embryonic stem cells, cell lines H1, H7, andH9 .d 1260 to 1854 1 to 595       595/595
(100 %)
1 diff
(99.9 %id)
DN913525   .d 1323 to 1407 19 to 103       85/103
(82 %)
6 diff
(94.2 %id)
TI_1959500061   .d 1768 to 2859 9 to 1097       1089/1248
(87 %)
15 diff
(98.8 %id)
TI_1968231587   .d 1768 to 2853 8 to 1083       1076/1295
(83 %)
29 diff
(97.8 %id)
BM907939 large cell carcinoma, lung .d 1834 to 2505 1 to 676       676/1166
(57 %)
5 diff
(99.6 %id)
BU193221 eye, retinoblastoma .d 1887 to 2743 1 to 871       871/883
(98 %)
16 diff
(98.2 %id)
TI_1959502223   .d 1934 to 3040 1099 to 3       1097/1285
(85 %)
14 diff
(99.0 %id)
BM827145 Ascites, stomach .d 1973 to 2250 1 to 278       278/278
(100 %)
0 diff
(100 %id)
AW858911 colon .d 2040 to 2516 7 to 483       477/493
(96 %)
16 diff
(96.8 %id)
AW858977 colon .d 2050 to 2506 466 to 11       456/466
(97 %)
0 diff
(100 %id)
BE072544 breast .d 2105 to 2233 7 to 135       129/136
(94 %)
3 diff
(97.8 %id)
BP279746   .d 2271 to 2852 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BP279788   .d 2271 to 2853 1 to 583       583/583
(100 %)
0 diff
(100 %id)
W26498 eye, retina .d 2285 to 2742 26 to 482       457/538
(84 %)
8 diff
(98.6 %id)
W27513 eye, retina .d 2299 to 2776 494 to 11       482/521
(92 %)
19 diff
(96.4 %id)
BF917555 uterus_tumor .d 2320 to 2487 168 to 1     Submitted on the opposite strand 168/168
(100 %)
0 diff
(100 %id)
BF917890 uterus_tumor .d 2320 to 2487 168 to 1     Submitted on the opposite strand 168/168
(100 %)
0 diff
(100 %id)
BI059750 uterus_tumor .d 2320 to 2487 168 to 1       168/168
(100 %)
0 diff
(100 %id)
TI_1959502225   .d 2375 to 3481 1100 to 7   tiling clone,   1096/1262
(86 %)
13 diff
(99.0 %id)
BQ072224 brain, neuroblastoma, cell line .d 2387 to 3194 1 to 808       808/1027
(78 %)
1 diff
(100.0 %id)
TI_1968233681   .d 2417 to 3484 1059 to 3       1059/1242
(85 %)
17 diff
(98.7 %id)
AW363686 colon .d 2563 to 3029 7 to 472       466/473
(98 %)
9 diff
(98.1 %id)
BF982668 duodenal adenocarcinoma, cell line, small intestine .d 2593 to 3197 1 to 624       624/648
(96 %)
13 diff
(98.0 %id)
TI_1959499091   .d 3032 to 4110 1181 to 116       1068/1299
(82 %)
19 diff
(98.6 %id)
BF769963 epid_tumor .d 3032 to 3249 219 to 2     Submitted on the opposite strand 218/224
(97 %)
1 diff
(99.6 %id)
BP313518 mammary gland .d 3043 to 3624 1 to 582       582/582
(100 %)
0 diff
(100 %id)
TI_1959503137   .d 3079 to 4110 1129 to 111   tiling clone,   1019/1260
(80 %)
24 diff
(98.1 %id)
BX494592 Liver .d 3213 to 3417 1 to 205       205/208
(98 %)
1 diff
(99.6 %id)
BP363381 lung .d 3290 to 3872 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BP278115   .d 3313 to 3899 1 to 588       588/588
(100 %)
1 diff
(99.9 %id)
BF739209 bladder_tumor .d 3337 to 3631 303 to 8     Submitted on the opposite strand 296/303
(97 %)
0 diff
(100 %id)
BP236581 coronary artery .d 3412 to 3992 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
TI_1959500067   .d 3481 to 4110 1 to 628       628/1258
(49 %)
8 diff
(99.4 %id)
TI_1971555993   .d 3488 to 4109 11 to 634     Submitted on the opposite strand 624/1292
(48 %)
12 diff
(99.1 %id)
BG109920 Bone, osteosarcoma, cell line .d 3615 to 4224 1 to 611       611/1019
(59 %)
9 diff
(99.2 %id)
BP336300 coronary artery .d 3744 to 4322 1 to 580       580/582
(99 %)
26 diff
(95.6 %id)
CF134581 CNCAP(3)T-225 cell line, Prostate .d 3894 to 4375 1 to 485       485/485
(100 %)
5 diff
(99.0 %id)
TI_154162610   .d 3899 to 4694 80 to 882       803/1108
(72 %)
45 diff
(96.0 %id)
BM801319 duodenal adenocarcinoma, cell line, small intestine .d 3945 to 4803 1 to 867   tiling clone,   867/918
(94 %)
21 diff
(97.8 %id)
BU630078 cell lines, Chondrosarcoma .d 4257 to 4747 639 to 149   AAA   491/497
(98 %)
0 diff
(100 %id)
T97804 liver and spleen .d 4379 to 4822 1 to 462       462/467
(98 %)
26 diff
(94.5 %id)
CB116546 Liver .d 4488 to 4941 459 to 6     Submitted on the opposite strand 454/459
(98 %)
0 diff
(100 %id)
BM475780 embryonal carcinoma, cell line, testis .d 4516 to 5147 1 to 645       645/959
(67 %)
36 diff
(96.3 %id)
DB266737 uterus .d 4519 to 5114 2 to 597   tiling clone, capped   596/596
(100 %)
1 diff
(99.9 %id)
W02403 liver and spleen .d 4528 to 5012 1 to 497   fully sequenced,   497/497
(100 %)
16 diff
(96.8 %id)
BQ773957 Bone, Human Chondrosarcoma Cell Line .d 4686 to 5288 1 to 603     Submitted on the opposite strand 603/612
(98 %)
4 diff
(99.4 %id)
CA419425 Bone, Human Chondrosarcoma Cell Line .d 4823 to 5434 628 to 17   tiling clone, AAA   612/612
(100 %)
0 diff
(100 %id)
AW674038 cervix .d 4898 to 5112 1 to 215       215/215
(100 %)
0 diff
(100 %id)
N72576 liver and spleen .d 4982 to 5429 450 to 1   fully sequenced,   450/450
(100 %)
5 diff
(98.9 %id)
BG260518 bladder, transitional cell papilloma, cell line .d 5060 to 5758 1 to 692   tiling clone,   692/944
(73 %)
14 diff
(98.6 %id)
AW074711 colon, juvenile granulosa tumor .d 5083 to 5429 353 to 1       353/357
(98 %)
13 diff
(96.4 %id)
AW003582 pooled germ cell tumors .d 5098 to 5434 365 to 29   AAA   337/337
(100 %)
14 diff
(95.9 %id)
AW235349 pooled germ cell tumors .d 5098 to 5434 365 to 29   AAA   337/337
(100 %)
22 diff
(93.5 %id)
AY605064   .d 5173 to 5415 1 to 243       243/243
(100 %)
0 diff
(100 %id)
BI059941 uterus_tumor .d 5273 to 5766 496 to 1       496/503
(98 %)
6 diff
(98.9 %id)
TI_154103509   .d 5348 to 6151 872 to 81   AAA   792/970
(81 %)
21 diff
(97.9 %id)
BG289903 bladder, transitional cell papilloma, cell line .d 5393 to 6074 1 to 693   tiling clone,   693/826
(83 %)
43 diff
(94.8 %id)
CK725165 Chondrosarcoma, Left Pubic Bone .d 5477 to 6151 693 to 19   tiling clone, AAA   675/675
(100 %)
5 diff
(99.3 %id)
BU601767 mixed (pool of 40 RNAs) .d 5504 to 6114 1 to 628       628/900
(69 %)
43 diff
(95.3 %id)
BU531909 mixed (pool of 40 RNAs) .d 5846 to 6146 1 to 301   AAA   301/301
(100 %)
2 diff
(99.4 %id)
AA722287   .d 5946 to 6397 451 to 1     Submitted on the opposite strand 451/451
(100 %)
1 diff
(99.8 %id)
BY997518   .d 6018 to 6639 1 to 622   tiling clone,   622/622
(100 %)
0 diff
(100 %id)
DB067575 testis .e 1 to 552 2 to 554 C2A tiling clone, capped   553/553
(100 %)
2 diff
(99.7 %id)
BM557378 amelanotic melanoma, cell line, skin .f-u 1 to 785 13 to 797 E2* tiling clone,   785/797
(98 %)
0 diff
(100 %id)
BM810946 amelanotic melanoma, cell line, skin .f-u 3 to 798 1 to 800   tiling clone,   800/1118
(71 %)
21 diff
(98.2 %id)
BX510210   .g 1 to 718 1 to 718 exact tiling clone,   718/718
(100 %)
1 diff
(99.9 %id)
DW410069 Liver .h 1 to 324 14 to 336   tiling clone,   323/336
(96 %)
11 diff
(96.8 %id)
CA421385 Bone, Enchondroma cell line Gene CLSPN, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g, .h Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI